Cybin inc. reports third quarter financial results and recent business highlights

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing psychedelics to therapeutics®, today reported unaudited financial results for its third quarter ended december 31, 2022, and recent business highlights. “looking ahead, we remain well-positioned to deliver on multiple near-term clinical milestones and data catalysts across our pipeline programs.
CYBN Ratings Summary
CYBN Quant Ranking